Regulatory Affairs and Drug and Device Development

Eric Gruff is the founder of E4 Consulting, which specializes in providing Regulatory Affairs, Pharmaceutical Development (CMC), Quality Assurance, and Project and Portfolio Management expertise to biotechnology and pharmaceutical clients. With over 30 years of experience in drug, biologic and medical device development, Eric is able to provide both strategic and operational assistance to companies that are bringing new drug, biologic and device candidates into clinical trials and beyond. Eric’s career history includes executive positions at Link Immunotherapeutics and Lengo Therapeutics (now Blueprint Medicines), and 11 years with Pfizer’s La Jolla Laboratories (formerly Agouron Pharmaceuticals). Eric received a BS in Chemistry from Rensselaer Polytechnic Institute and subsequently obtained his PhD in Chemistry from SUNY Stony Brook. He then spent two years as a postdoctoral fellow at the Salk Institute for Biological Studies in La Jolla, CA working with Professor Leslie Orgel on the development of novel platinum-based DNA crosslinking agents as potential antisense therapeutics. Eric also holds an Executive MBA degree from San Diego State University.